Scientists are perplexed by the low rate of coronavirus hospitalizations among smokers. Nicotine may hold the answer.

No experts are remotely advocating for people to take up smoking to prevent COVID-19, but some researchers have theorized nicotine may be playing some role in keeping the virus at bay, Vice reports. That's because there's a surprisingly low rate of smokers among coronavirus hospitalizations.
In France, for example, 25 percent of the population smokes, but only 5.3 percent of coronavirus patients have been recorded as smokers, and studies have found low rates in China and New York City, as well.
Greek cardiologist and tobacco harm-reduction specialist Konstantinos Farsalinos thinks nicotine (crucially, not tobacco) might be lessening the intensity of cytokine storms, an overreaction of the body's immune system which seems to be the cause of the most severe coronavirus symptoms. French researchers have a slightly altered theory that nicotine prevents the virus from entering cells (the difference lies in the type of receptors the virus latches onto), and they're hoping to test out nicotine patches on patients to see if they help fight off COVID-19. The French government suspended the online sale of patches to make sure people don't buy in bulk and try to treat themselves that way.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The seemingly out-there theory has piqued the interest of scientists across the world, though many are urging caution. The lower rates could be a result of some other chemical in tobacco producing a protective effect, or it could be that the number of smokers is being underreported.
"Smokers who have developed chronic disease have likely quit because of their disease," Michael Siegel, a community health sciences professor at Boston University, said. "Many of the smokers who are continuing to smoke are doing so because they don't have disease yet. So this would be expected to skew the sample of hospitalized patients toward people who do not smoke." Read more at Vice.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Celebrating 250 years of Jane Austen
The Week Recommends From exhibitions to Regency balls, these are the best ways to commemorate the author
By Irenie Forshaw, The Week UK Published
-
The pressure of South Korea's celebrity culture
In The Spotlight South Korean actress Kim Sae-ron was laid to rest on Wednesday after an apparent suicide
By Abby Wilson Published
-
Should lying in politics be a criminal offence?
Today's Big Question Welsh government considers new crime of deliberate deception by an elected official
By Richard Windsor, The Week UK Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published